scorecardresearch
Saturday, September 13, 2025
TopicCancer treatment

Topic: Cancer treatment

Biocon Biologics joins Novartis, Pfizer to distribute cancer drugs in lower-income countries

Biocon Biologics partnered with international organisations to enhance access to life-saving cancer drugs for patients, especially in Sub-Saharan and Asian regions.

ICMR seeks govt panel approval to test cancer drug in WHO’s Covid Solidarity trial

The Subject Expert Committee deliberated on the matter on 9 October and asked ICMR to submit 'clarifications and justifications' for inclusion of acalabrutinib in the trial.

US approves tablet for blood cancer so patients can avoid hospital visit for chemotherapy

The drug is a combination of ‘decitabine and cedazuridine’, which are used as agents for chemotherapy. But it may not be affordable for a large section of Indian patients.

Targeted therapy can weaponise cells to kill cancer, says oncologist Siddhartha Mukherjee

Speaking at ThePrint's Off The Cuff, Dr Siddhartha Mukherjee speaks about advanced cancer treatment, its dilemmas, ethics surrounding clinical trials.

Targeting a single cell that begins tumours can revolutionise cancer treatment

If we focus our attack on energetic cancer stem cells, we may be able to directly hit the target.

As Ananth Kumar passes away, a look at politicians who have beaten or succumbed to cancer

Union minister Ananth Kumar died Monday of cancer, a disease that also afflicts his former ministerial colleague Manohar Parrikar.

On Camera

Russian-style socialism dominated Nehru’s imagination. It was disastrous

It is necessary to break the spell of socialist dogma on the imagination of those attracted by its Utopia as the only scientific way of progress, wrote MA Venkatarao in 1963.

What’s behind bond yields’ logic-defying spike? The market’s concern over the future

While bond yields tend to fall amid low inflation & interest rate cuts, market experts say they’ve been rising due to concerns over tax collections, fiscal deficit & potential impact of US tariffs.

Navy gets first Tata-made Spanish 3D surveillance radar for its warships, 19 more to come

It is one of the most advanced long-range air defence and anti-missile radars. It has been acquired under an about USD 145-million deal signed in 2020.

Gen Zs have taken down the Nepal regime. Here’s why this will never happen in India

To be truly functional and durable, even eternal, a state doesn’t just need a leader, a party or an ideology. It needs functional and robust institutions.